Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

(2002). Sulfonylurea receptor type 1 knock–out mice have intact feeding–
stimulated insulin secretion despite marked impairment in their response to
glucose. J. Biol. Chem, 277: 37176–37183.
Shorr SS, Bloom FE. (1970). Fine structure of islet–cell innervation in the pancreas of
normal and alloxan–treated rats. Z Zellforsch Mikrosk Anat, 103: 12–25.
Sicree R, Shaw J, Zimmet P. (2006). Diabetes and impaired glucose tolerance. in
Diabetes Atlas, 3rd edition, Gan D, (Ed)., International Diabetes Federation:
Brussels. P: 15–109.
Siddiqui MF, Levey AI. (1999). Cholinergic therapies in Alzheimer’s disease. Drugs
Future, 24: 417–444.
Silva AJ, Jeffrey HK, Paul WF, Satoshi K. (1998). Creb and Memory. Annu Rev
Neurosci, 21: 127–148.
Singh P, Jain A, Kaur G. (2004). Impact of hypoglycemia and diabetes on CNS:
correlation of mitochondrial oxidative stress with DNA damage. Mol Cell
Biochem, 260: 153–159.
Sivilotti L, Nistri A. (1991). GABA receptor mechanisms in the central nervous
system. Prog Neurobiol, 36: 35–92.
Sloviter RS, Nilaver G. (1987). Immunocytochemical localization of GABA–
cholecystokinin–vasoactive intestinal polypeptide and somatostatin–like
immunoreactivity in the area dentata and hippocampus of the rat. J Comp Neurol,
256: 42–60.